Geode Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Geode Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-44,698	Closed	-$71.5K	–	4880
2023 Q1	$71.5K	Hold	44,698	–	–	﹤0.01%	4437
2022 Q4	$87K	Sell	44,698 -82	-0.2%	-$202	﹤0.01%	4445
2022 Q3	$155K	Buy	44,780 +10,356	+30%	+$39.5K	﹤0.01%	4351
2022 Q2	$117K	Sell	34,424 -95	-0.3%	-$524	﹤0.01%	4530
2022 Q1	$315K	Buy	34,519 +1,560	+5%	+$23.7K	﹤0.01%	4160
2021 Q4	$708K	Sell	32,959 -6,239	-16%	-$167K	﹤0.01%	3877
2021 Q3	$1.28M	Buy	39,198 +7,956	+25%	+$291K	﹤0.01%	3557
2021 Q2	$1.3M	Sell	31,242 -20,390	-39%	-$1.04M	﹤0.01%	3472
2021 Q1	$3.38M	Buy	51,632 +18,053	+54%	+$1.26M	﹤0.01%	2979
2020 Q4	$2.21M	Buy	33,579 +1,428	+4%	+$93.1K	﹤0.01%	3028
2020 Q3	$1.75M	Buy	32,151 +431	+1%	+$33K	﹤0.01%	2943
2020 Q2	$3.03M	Buy	31,720 +1,434	+5%	+$107K	﹤0.01%	2606
2020 Q1	$1.55M	Buy	30,286 +3,507	+13%	+$367K	﹤0.01%	2810
2019 Q4	$2.2M	Buy	26,779 +551	+2%	+$38.6K	﹤0.01%	2947
2019 Q3	$2.24M	Buy	26,228 +42	+0.2%	+$4.48K	﹤0.01%	2882
2019 Q2	$3.34M	Buy	26,186 +1,676	+7%	+$241K	﹤0.01%	2633
2019 Q1	$4.42M	Buy	24,510 +4,804	+24%	+$695K	﹤0.01%	2403
2018 Q4	$2.19M	Buy	19,706 +828	+4%	+$108K	﹤0.01%	2725
2018 Q3	$2.55M	Buy	18,878 +956	+5%	+$132K	﹤0.01%	2755
2018 Q2	$2.47M	Buy	17,922 +1,228	+7%	+$169K	﹤0.01%	2734
2018 Q1	$2.3M	Buy	16,694 +144	+0.9%	+$19.6K	﹤0.01%	2687
2017 Q4	$2.04M	Buy	16,550 +323	+2%	+$44.4K	﹤0.01%	2740
2017 Q3	$2.21M	Buy	16,227 +971	+6%	+$147K	﹤0.01%	2683
2017 Q2	$2.68M	Buy	15,256 +44	+0.3%	+$6.26K	﹤0.01%	2556
2017 Q1	$1.82M	Buy	15,212 +542	+4%	+$56.4K	﹤0.01%	2724
2016 Q4	$1.43M	Buy	14,670 +279	+2%	+$25.6K	﹤0.01%	2815
2016 Q3	$1.35M	Buy	14,391 +283	+2%	+$28.4K	﹤0.01%	2780
2016 Q2	$1.52M	Buy	14,108 +113	+0.8%	+$13.2K	﹤0.01%	2664
2016 Q1	$1.68K	Buy	13,995 +335	+2%	+$35.2K	﹤0.01%	2572
2015 Q4	$1.63M	Buy	13,660 +1,350	+11%	+$174K	﹤0.01%	2597
2015 Q3	$2.1M	Buy	12,310 +383	+3%	+$73.4K	﹤0.01%	2410
2015 Q2	$2.31M	Buy	11,927 +534	+5%	+$99.1K	﹤0.01%	2406
2015 Q1	$1.69M	Buy	11,393 +1,259	+12%	+$192K	﹤0.01%	2551
2014 Q4	$1.58M	Buy	10,134 +1,169	+13%	+$168K	﹤0.01%	2570
2014 Q3	$1.28M	Buy	8,965 +332	+4%	+$48.1K	﹤0.01%	2633
2014 Q2	$1.13M	Sell	8,633 -1,297	-13%	-$165K	﹤0.01%	2731
2014 Q1	$1.22M	Sell	9,930 -1,312	-12%	-$142K	﹤0.01%	2655
2013 Q4	$1.19M	Buy	11,242 +275	+3%	+$26.7K	﹤0.01%	2609
2013 Q3	$1.23M	Buy	10,967 +536	+5%	+$60.8K	﹤0.01%	2477
2013 Q2	$1.18M	Buy	+10,431	New	+$1.28M	﹤0.01%	2374

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management's SRGA Position: Q2 2023 in Review

Geode Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 44,698 shares — an estimated $71.5K sold.

Geode Capital Management first reported a position in SRGA in Q2 2013 and held it in 40 quarters. The position peaked at $4.42M in Q1 2019. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

Geode Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Geode Capital Management sold 44,698 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $71.5K.
Geode Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
Geode Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $4.42M in Q1 2019.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.